The use of Teflon cell culture bags to expand functionally active CD8+ cytotoxic T lymphocytes

被引:11
作者
Garland, RJ
Kaneria, SS
Hancock, JP
Steward, CG
Rowbottom, AW
机构
[1] Univ Bristol, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England
[2] Royal Hosp Sick Children, Dept Paediat Haematol, Bristol BS2 8BJ, Avon, England
关键词
CD8; bag; expansion; Teflon; human;
D O I
10.1016/S0022-1759(99)00068-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the ability of Teflon cell culture (TCC) bags, compared to conventional tissue culture flasks and plates, to support the expansion of human CD8(+) T cells in response to an allogeneic stimulus. TCC bags, which are compatible with good manufacturing practice (GMP), facilitated CD8(+) T cell growth as well as conventional culture vessels and resulted in cytotoxic T cells which were able to kill allogeneic targets. Growth characteristics were compared by investigating the number, immunophenotype and cell cycle properties of the cells generated. The kinetics of cell growth were not significantly different over the first 14 days of culture in each vessel type, with the cell counts being highest at day 10 in all cases. However, the TCC bags resulted in a significantly higher proportion of cells with the morphology of typical lymphocytes than tissue culture flasks after 14 and 18 days in culture. There were no significant differences in the percentage of typical lymhocytes expanded in TCC bags compared to those expanded in plates. Expanded CD8(+) cells maintained their initial level of expression of CD3, CD11a, CD18 and T cell receptor (alpha beta heterodimer, TCR (alpha beta)) but increased expression of CD45RO, CD95 and of activation markers HLA-DR and CD25 in each culture vessel. Studies of cell cycle parameters showed that each vessel supported CD8(+) T cell stimulation, as demonstrated by significantly higher levels of S phase than fresh PBMN cells, The cells generated in TCC bags were able to kill allogeneic targets and also possessed natural killer (NK) cell activity. Thus, TCC bags are able to support the expansion of CD8(+) T lymphocytes as well as flasks or tissue culture plates and are applicable to lymphocyte expansion for use in immunotherapy. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:53 / 63
页数:11
相关论文
共 21 条
[1]   A SIMPLIFIED AUTOMATED PROCEDURE FOR GENERATION OF HUMAN LYMPHOKINE-ACTIVATED KILLER CELLS FOR USE IN CLINICAL-TRIALS [J].
AEBERSOLD, P ;
CARTER, CS ;
HYATT, C ;
JOHNSON, S ;
OTTAWAY, K ;
LEITMAN, SF ;
ROSENBERG, SA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 112 (01) :1-7
[2]   CLONAL ACTIVATION OF CYTOTOXIC LYMPHOCYTE PRECURSORS BY MONOCLONAL ANTI-CD3 ANTIBODY - ANALYSIS OF FEEDER CELL REQUIREMENTS [J].
BRUCKER, C ;
REIMANN, J ;
WAGNER, H ;
KABELITZ, D .
IMMUNOLOGY LETTERS, 1987, 14 (02) :121-125
[3]  
Chai JG, 1998, J IMMUNOL, V160, P3655
[4]   In vitro production of human antigen presenting cells issued from bone marrow of patients with cancer [J].
Coulon, V ;
Ravaud, A ;
Huet, S ;
Gualde, N .
HEMATOLOGY AND CELL THERAPY, 1997, 39 (05) :237-244
[5]   DONOR LEUKOCYTE INFUSION AS THERAPY OF LIFE-THREATENING ADENOVIRAL INFECTIONS AFTER T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION [J].
HROMAS, R ;
CORNETTA, K ;
SROUR, E ;
BLANKE, C ;
BROUN, ER .
BLOOD, 1994, 84 (05) :1689-1690
[6]   AUTOLOGOUS TUMOR-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T IN THE INFILTRATE OF HUMAN METASTATIC MELANOMAS - ACTIVATION BY INTERLEUKIN-2 AND AUTOLOGOUS TUMOR-CELLS, AND INVOLVEMENT OF THE T-CELL RECEPTOR [J].
ITOH, K ;
PLATSOUCAS, CD ;
BALCH, CM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (04) :1419-1441
[7]   OPTIMIZATION OF CULTURE CONDITIONS FOR ACTIVATION AND LARGE-SCALE EXPANSION OF HUMAN LYMPHOCYTES-T FOR BISPECIFIC ANTIBODY-DIRECTED CELLULAR IMMUNOTHERAPY [J].
LAMERS, CHJ ;
VANDEGRIEND, RJ ;
BRAAKMAN, E ;
RONTELTAP, CPM ;
BENARD, J ;
STOTER, G ;
GRATAMA, JW ;
BOLHUIS, RLH .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (06) :973-979
[8]   The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia [J].
Lowdell, MW ;
Ray, N ;
Craston, R ;
Corbett, T ;
Deane, M ;
Prentice, HG .
BONE MARROW TRANSPLANTATION, 1997, 19 (09) :891-897
[9]   ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE [J].
MACKINNON, S ;
PAPADOPOULOS, EB ;
CARABASI, MH ;
REICH, L ;
COLLINS, NH ;
BOULAD, F ;
CASTROMALASPINA, H ;
CHILDS, BH ;
GILLIO, AP ;
KERNAN, NA ;
SMALL, TN ;
YOUNG, JW ;
OREILLY, RJ .
BLOOD, 1995, 86 (04) :1261-1268
[10]   DIRECT DEMONSTRATION OF THE CLONOGENIC POTENTIAL OF EVERY HUMAN PERIPHERAL-BLOOD T-CELL - CLONAL ANALYSIS OF HLA-DR EXPRESSION AND CYTOLYTIC ACTIVITY [J].
MORETTA, A ;
PANTALEO, G ;
MORETTA, L ;
CEROTTINI, JC ;
MINGARI, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (02) :743-754